Jiqin Zhang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study.
Journal: EClinicalMedicine
Published: March 19, 2023
Enhancing the Antitumor Immunity of T Cells by Engineering the Lipid-Regulatory Site of the TCR/CD3 Complex.
Journal: Cancer immunology research
Published: December 29, 2021
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL.
Journal: Nature
Published: March 29, 2021
UHRF2 promotes intestinal tumorigenesis through stabilization of TCF4 mediated Wnt/β-catenin signaling.
Journal: International journal of cancer
Published: January 29, 2020
Correction to: Increasing targeting scope of adenosine base editors in mouse and rat embryos through fusion of TadA deaminase with Cas9 variants.
Journal: Protein & cell
Published: May 16, 2019
Increasing targeting scope of adenosine base editors in mouse and rat embryos through fusion of TadA deaminase with Cas9 variants.
Journal: Protein & cell
Published: August 02, 2018
Interleukin‑22 regulates the homeostasis of the intestinal epithelium during inflammation.
Journal: International journal of molecular medicine
Published: July 09, 2018
The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Journal: Cancer letters
Published: April 19, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026